Biotech / Medical
Misonix Inc. (MSON)
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
941 9 0 MSON
Emcee:  DAVID BROWN Type:  Unmoderated
This has been a strong mover lately. Anyone follow this one or have any thoughts? They recently licenced some type of new surgical technology to Us Surgical.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
941Misonix Reports Fiscal Year 2017 Financial Results FARMINGDALE, N.Y., Aug. 22, Savant-8/23/2017
940So, MSON from 3.83 low to 12.00 high, over last yearSavant-4/28/2017
939 Misonix Files Form 10-K Announcing Fiscal 2016 Financial Results 4:15 PM ET Savant-2/9/2017
938DEC 19...Misonix, Inc. (NASDAQ: MSON), a leading provider of ultrasonic surgicalSavant-12/19/2016
937CC today, plus... FARMINGDALE, N.Y., Aug. 20, 2015 /PRNewswire/ -- Misonix, IncSavant-8/20/2015
936 Additional Data Confirms Reduction In Blood Loss With Misonix SonicOSavant-4/30/2015
935 Misonix Announces Exclusive Supply Agreement With MedAssets For BoneSavant-4/30/2015
934 Misonix Announces Presentation At Leading Wound Conference ConfirmsSavant13/18/2015
933Misonix, Inc. Announces Second Quarter Fiscal Year 2015 Financial Results Savant12/4/2015
932MISONIX, Inc. (MISONIX) has released its latest clinical publication, Savant-12/17/2014
931 Misonix, Inc. Announces Fourth Quarter and Fiscal Year End 2014 Financial ResuSavant19/11/2014
930 Misonix, Inc. Enhances its Digital Presence with the Unveiling of itSavant-7/24/2014
929 Misonix BoneScalpel(TM) Reported to Save Blood Loss in Spinal FusionSavant-7/15/2014
928 Ultrasonic BoneScalpel(TM) Making Spine Surgery Safe and EfficientFASavant-6/4/2014
927 Poster Featuring Misonix BoneScalpel(TM) Wins Best in Show Award at Savant-1/30/2014
926 Misonix Exhibits at the Annual New York Podiatric Clinical ConferencSavant-1/30/2014
925Misonix Exhibits at the Annual Medstar Georgetown Diabetic Limb Salvage ConferenSavant-10/22/2013
924 Misonix, Inc. Terminates Agreement with PuriCoreFARMINGDALE, N.Y., Oct. 11, 201Savant-10/16/2013
923Misonix, Inc. Receives Clearance for the Sale of the BoneScalpel(TM) in the PeopSavant-7/16/2013
922Misonix, Inc. (NASDAQ: MSON), a surgical device company that designs, manufacturSavant-5/14/2013
921Denmark... FARMINGDALE, N.Y., April 2, 2013 /PRNewswire/ -- Misonix, Inc. ( MSavant-4/5/2013
920Misonix BoneScalpel(TM) Highlighted In New Clinical Paper Aimed At Face And Jaw Savant-3/6/2013
919Misonix BoneScalpel(TM) Subject Of New Clinical Paper FARMINGDALE, N.Y., Jan. Savant-2/4/2013
918Misonix Presents at MicroCapClub Invitational Company Invites Investors to VieSavant-2/4/2013
917Misonix, Inc. To Report Financial Results Of Second Quarter Fiscal 2013 On ThurSavant-2/4/2013
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2018 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.